Bio-engineered peptides with self-regulating property to combat overall inflammation, tumour markers and cancer metastasis

Learning Objectives:

  • Introduction to the newly discovered, bio-engineered peptides as an effective inflammatory cascade blocker that down regulate elevated inflammation markers for anti-aging and chronic disease treatments.
  • An insight into the application protocols and successful clinical trials demonstrating significant fat loss and muscle gain

Abstract:

Combating Inflammation – A New Approach to Disease Treatment and Prevention

Inflammation is a natural and healthy immune reaction that happens on the cellular level. During an injury or in the presence of infection, the immune system will instinctively orchestrate a surge of specific cells and bio-chemicals to the target sites, resulting in a systemic response in the form of inflammation.

Known widely as a sort of biological conundrum, inflammation protects our body and causes it to deteriorate as well. The insidious development of chronic ‘hidden’ inflammation due to the malfunctioned control signals of the immune system is scientifically proven to be detrimental to health, and often goes unnoticed as chronic inflammation typically falls below the sensory threshold of perceived pain. This faulty process renders a constant supply of free radicals that damages cellular DNA and overwhelms the antioxidant defenses – which also inherently contributes to aging. Ultimately, it triggers the genes within cells that are preprogrammed to certain diseases.

Regenapep – ‘The Inflammatory Blocker’

Bio-engineered as an outstanding inflammatory cascade blocker, Regenapep is capable of inducing suppressive effect on the development of chronic systemic inflammations. This peptide-derived interleukin blocker has a unique self-limiting ability to down regulate elevated inflammation markers with outstanding effectiveness by specifically inhibiting selective interleukins.
Regenapep is crystallized from a series of laboratory investigations conducted by Lab RMS on the selective blocking of the production of prostaglandins – the regulatory molecules. By bio-engineering a specialized amino acid complex that functions as an inhibitor to the production of these regulatory molecules, chronic systemic inflammation and tumor growth can be curbed while avoiding the cardiovascular side effects of pharmaceutical drugs such as Vioxx and the gastrointestinal problems of the earlier classes of steroids.

When a cytokine blood profile is conducted on people in a weakened condition, an excess level of one or more of the inflammatory cytokines, e.g. Tumor Necrosis Factor Alpha (TNF-a), Interleukin-1 Beta (IL-1β), Interleukin 6 (IL-6) or Interleukin 8 (IL-8), is usually found. Through the consistent administration of Regenapep, lowered blood levels of some of the most common markers of advanced aging and diseases can be achieved.

Produced as a profound anti-inflammatory agent with GMP pharmaceutical grade, Regenapep is specifically designed to block this cascade in order to stop the elevated inflammation in the body. Even after a traumatic injury testing, this innovative peptide-based treatment is able to responsively modulate excessive inflammation to accelerate healing and repair.

Protocol:

  • Chronic Disease Treatment  -  1-5ml injection every 3 days until condition abates
  • Anti-aging and Wellness  -  1-5ml injection every 3 days

Indications:

Aging, allergy, Alzheimer’s disease, anemia, aortic valve stenosis, arthritis, asthma, cancer, gastritis, congestive heart failure, fibromyalgia, fibrosis, pancreatitis, prostatis, psoriasis, surgical complications, obesity, diabetes, eczema, high blood pressure, high cholesterol, colitis, acne etc.

 

Download the PDF